AGXT2L1 antibody
Principal name
AGXT2L1 antibody
Alternative names for AGXT2L1 antibody
Alanine-glyoxylate aminotransferase 2-like 1
Ncbi ID
NP_112569, NM_031279, NM_001146627, NM_001146590, NP_001140062.1, NP_001157059.1, NM_001163587, NM_027907
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of AGXT2L1 antibody
- Kit Component:
- - KN305400G1, Agxt2l1 gRNA vector 1 in pCas-Guide vector
- KN305400G2, Agxt2l1 gRNA vector 2 in pCas-Guide vector
- KN305400D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human PANC1; WB Suggested Anti-AGXT2L1 Antibody Titration: 0.2-1 ug/ml. Positive Control: PANC1 cell lysate; AGXT2L1 antibody - middle region (ARP48948_P050) in Human PANC1 cells using Western Blot
AGXT2L1 antibody detects AGXT2L1 protein by Western blot analysis. A. 50 ug mouse kidney lysate/extract. 7.5 % SDS-PAGE. AGXT2L1 antibody (TA308428) dilution: 1:500
Sample(30 ug of whole cell lysate). A:293T. 7.5% SDS PAGE. TA308428 diluted at 1:500
Immunohistochemical analysis of paraffin-embedded normal gastric epithelium (gland), using AGXT2L1(TA308428) antibody at 1:100 dilution.
WB Suggested Anti-AGXT2L1 Antibody Titration: 0.2-1 ug/ml; Positive Control: PANC1 cell lysate
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP305429 | AGXT2L1 |
||||
| Recombinant protein of human alanine-glyoxylate aminotransferase 2-like 1 (AGXT2L1) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY410615 | ETNPPL overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY431381 | ETNPPL overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY431436 | ETNPPL overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR217098L2V | Lenti ORF particles, Agxt2l1 (GFP-tagged) - Mouse alanine-glyoxylate aminotransferase 2-like 1 (Agxt2l1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,190.00
|
|
| OriGene Technologies, Inc. | ||
| MR207999L2V | Lenti ORF particles, Agxt2l1 (GFP-tagged) - Mouse alanine-glyoxylate aminotransferase 2-like 1 (Agxt2l1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR217098L1V | Lenti ORF particles, Agxt2l1 (Myc-DDK-tagged) - Mouse alanine-glyoxylate aminotransferase 2-like 1 (Agxt2l1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,060.00
|
|
| OriGene Technologies, Inc. | ||
| MR207999L1V | Lenti ORF particles, Agxt2l1 (Myc-DDK-tagged) - Mouse alanine-glyoxylate aminotransferase 2-like 1 (Agxt2l1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||